- Home
- GPK vs CORT Comparison
GPK vs CORT Comparison
Compare GPK & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPK
- CORT
- Stock Information
- Founded
- GPK 2007
- CORT 1998
- Country
- GPK United States
- CORT United States
- Employees
- GPK N/A
- CORT N/A
- Industry
- GPK Containers/Packaging
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- GPK Consumer Discretionary
- CORT Health Care
- Exchange
- GPK Nasdaq
- CORT Nasdaq
- Market Cap
- GPK 6.1B
- CORT 7.6B
- IPO Year
- GPK 1992
- CORT N/A
- Fundamental
- Price
- GPK $20.21
- CORT $69.53
- Analyst Decision
- GPK Buy
- CORT Strong Buy
- Analyst Count
- GPK 8
- CORT 4
- Target Price
- GPK $26.38
- CORT $139.00
- AVG Volume (30 Days)
- GPK 3.6M
- CORT 644.6K
- Earning Date
- GPK 10-28-2025
- CORT 10-29-2025
- Dividend Yield
- GPK 2.18%
- CORT N/A
- EPS Growth
- GPK N/A
- CORT N/A
- EPS
- GPK 1.77
- CORT 1.11
- Revenue
- GPK $8,635,000,000.00
- CORT $716,080,000.00
- Revenue This Year
- GPK N/A
- CORT $30.62
- Revenue Next Year
- GPK $1.68
- CORT $37.68
- P/E Ratio
- GPK $11.40
- CORT $62.97
- Revenue Growth
- GPK N/A
- CORT 25.71
- 52 Week Low
- GPK $20.15
- CORT $37.82
- 52 Week High
- GPK $30.70
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- GPK 34.37
- CORT 45.26
- Support Level
- GPK $20.38
- CORT $67.32
- Resistance Level
- GPK $21.24
- CORT $74.79
- Average True Range (ATR)
- GPK 0.55
- CORT 2.36
- MACD
- GPK -0.16
- CORT 0.14
- Stochastic Oscillator
- GPK 2.39
- CORT 29.58
About GPK Graphic Packaging Holding Company
Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Paperboard Manufacturing, Americas Paperboard Packaging, and Europe Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company generates revenue from the Americas, Europe and Asia Pacific regions.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.